Clinical Trial: MYLUNG Consortium Study Protocol 2
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: Carcinoma, Non-Small-Cell Lung
Study Type: Observational [Patient Registry]
Official Title: Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Pragmatic Prospective RWE Study (MYLUNG Consortium: Part 2)
Brief Summary:
This pragmatic study looks to quantify the testing timeline, operational barriers, and outcomes of biomarker-guided therapy in a large, community-based, and largely unselected patient population with early stage and advanced stage, treatment-naive non-small cell lung cancer, whether squamous or non-squamous.
Read more